James T. Borello RIA
VRTX icon

James T. Borello RIA’s Vertex Pharmaceuticals VRTX Stock Holding History

James T. Borello RIA’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$50.2K Hold
96
– – 0.01% 246
2026
Q2 		$47.7K Buy
96
+11
+13% +$4.88K 0.01% 243
2026
Q1 		$38K Buy
85
+35
+70% +$16.3K 0.01% 255
2025
Q4 		$22.7K Buy
50
+20
+67% +$8.62K 0.01% 263
2025
Q3 		$11.7K Buy
+30
New +$12.5K ﹤0.01% 290

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

James T. Borello RIA's VRTX Position: Q3 2026 in Review

James T. Borello RIA held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 96 shares worth $50.2K. The position accounts for 0.01% of the portfolio, ranked #246.

James T. Borello RIA first reported a position in VRTX in Q3 2025 and has held it in 5 quarters since. 346 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • James T. Borello RIA held 96 shares of Vertex Pharmaceuticals worth $50.2K as of Q3 2026.
  • James T. Borello RIA left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.01% of James T. Borello RIA's portfolio in Q3 2026, its #246 holding.
  • James T. Borello RIA first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 346 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.